1
Sequencing Strategies in Metastatic Prostate Cancer: Revealing the CARDs ESMO 2019 Industry Satellite Symposium Sunday, 29 September 2019 18:30–20:00 Bilbao Auditorium, Hall 5 Fira Gran Via Barcelona, Spain ©Ana Maria Edulescu. All rights reserved. AGENDA FACULTY 18:30-18:35 Welcome and Introduction Dr. Bertrand Tombal and Dr. Joan Carles 18:35-18:55 Shuffling the Cards in the Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treatment Paradigm Dr. Bertrand Tombal 18:55-19:15 Raising the Stakes in Prospective Sequencing Studies in mCRPC Dr. Kim Chi 19:15-19:30 Playing the Best Hand in Sequencing Strategies for mCRPC: Retrospective and Registry Studies Dr. Joan Carles 19:30-19:45 An Ace in Treatment Sequencing for Metastatic Hormone- Sensitive Prostate Cancer (mHSPC) Dr. Alicia Morgans 19:45-20:00 Q&A and Closing Remarks Dr. Bertrand Tombal Bertrand Tombal, MD, PhD (co-chair) Cliniques Universitaires Saint-Luc, CUSL Brussels, Belgium Joan Carles, MD, PhD (co-chair) Vall d’Hebron Institute of Oncology Barcelona, Spain Kim Chi, MD BC Cancer Agency Vancouver, British Columbia, Canada Alicia Morgans, MD, MPH Northwestern University Feinberg School of Medicine Chicago, Illinois, USA SAGLB.CAB.19.04.0435(1)a (07/19) BARCELONA 2019

Metastatic Prostate Cancer: Revealing the CARDs · 19:30-19:45 An Ace in Treatment Sequencing for Metastatic Hormone- Sensitive Prostate Cancer (mHSPC) Dr. Alicia Morgans 19:45-20:00

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Metastatic Prostate Cancer: Revealing the CARDs · 19:30-19:45 An Ace in Treatment Sequencing for Metastatic Hormone- Sensitive Prostate Cancer (mHSPC) Dr. Alicia Morgans 19:45-20:00

Sequencing Strategies in Metastatic Prostate Cancer: Revealing the CARDs

ESMO 2019 Industry Satellite Symposium

Sunday, 29 September 201918:30–20:00Bilbao Auditorium, Hall 5 Fira Gran ViaBarcelona, Spain

©Ana Maria Edulescu. All rights reserved.

AGENDA FACULTY18:30-18:35 Welcome and Introduction Dr. Bertrand Tombal and Dr. Joan Carles

18:35-18:55 Shuffling the Cards in the Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treatment Paradigm Dr. Bertrand Tombal

18:55-19:15 Raising the Stakes in Prospective Sequencing Studies in mCRPC Dr. Kim Chi

19:15-19:30 Playing the Best Hand in Sequencing Strategies for mCRPC: Retrospective and Registry Studies Dr. Joan Carles

19:30-19:45 An Ace in Treatment Sequencing for Metastatic Hormone- Sensitive Prostate Cancer (mHSPC) Dr. Alicia Morgans

19:45-20:00 Q&A and Closing Remarks Dr. Bertrand Tombal

Bertrand Tombal, MD, PhD (co-chair) Cliniques Universitaires Saint-Luc, CUSL Brussels, Belgium

Joan Carles, MD, PhD (co-chair) Vall d’Hebron Institute of Oncology Barcelona, Spain

Kim Chi, MD BC Cancer Agency Vancouver, British Columbia, Canada

Alicia Morgans, MD, MPH Northwestern University Feinberg School of Medicine Chicago, Illinois, USA

SAGLB.CAB.19.04.0435(1)a (07/19)

BARCELONA2019